Pheochromocytoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Preoperative treatment of pheochromocytoma is the best way to reduce complications and postoperative follow up is the | Preoperative treatment of pheochromocytoma is the best way to reduce complications and postoperative follow up is the optimal method to reduce recurrence. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
| Line 15: | Line 15: | ||
*Genetic testing should be performed in:<sup>[[Pheochromocytoma screening#cite note-pmid24893135-2|[2]]]</sup> | *Genetic testing should be performed in:<sup>[[Pheochromocytoma screening#cite note-pmid24893135-2|[2]]]</sup> | ||
**Patients with a [[family history]] of pheochromocytoma | **Patients with a [[family history]] of pheochromocytoma | ||
**Bilateral or multifocal lesions | **[[Bilateral]] or multifocal lesions | ||
**[[Tumors]] or [[malignant]] or extra-adrenal pheochromocytoma | **[[Tumors]] or [[malignant]] or extra-adrenal pheochromocytoma | ||
**Young patients who are aged 50 years or under | **Young patients who are aged 50 years or under | ||
Revision as of 19:10, 26 September 2019
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma secondary prevention |
|
Risk calculators and risk factors for Pheochromocytoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
Overview
Preoperative treatment of pheochromocytoma is the best way to reduce complications and postoperative follow up is the optimal method to reduce recurrence.
Secondary Prevention
- Recurrence is lower than 10%.[1]
- Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and hypotension after it.
- All patients with pheochromocytoma need postoperative follow up by the following methods:[2]
- Patients should undergo baseline postoperative biochemical testing and annual lifelong tests.[3]
- The noncatecholamine-producing tumor should undergo annual imaging with CT or MRI to monitor for recurrence.[4]
- Genetic testing should be performed in:[2]
- Patients with a family history of pheochromocytoma
- Bilateral or multifocal lesions
- Tumors or malignant or extra-adrenal pheochromocytoma
- Young patients who are aged 50 years or under
References
- ↑ Hu K, Persky MS (2003). "Multidisciplinary management of paragangliomas of the head and neck, Part 1". Oncology (Williston Park). 17 (7): 983–93. PMID 12886866.
- ↑ Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF (2005). "Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma". J Clin Endocrinol Metab. 90 (4): 2110–6. doi:10.1210/jc.2004-1398. PMID 15644401.
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.